Literature DB >> 6386580

Differential binding of sulphated insulin to adipocytes and hepatocytes.

S Zeuzem, R Taylor, L Agius, A M Albisser, K G Alberti.   

Abstract

The polymerization and precipitation of highly purified insulins which causes major problems in portable infusion systems does not occur with sulphated insulin. To compare the biological behaviour of sulphated insulin with that of a neutral highly purified monocomponent insulin, insulin receptor studies were performed on human and rat adipocytes and rat hepatocytes. Sulphated insulin displayed a lower affinity for binding to both human and rat adipocytes compared with neutral insulin, approximately four times the concentration being required to achieve half-maximal displacement of monoiodoinsulin (p less than 0.05 and 0.01, respectively). A 20-fold higher concentration of sulphated insulin was required for half-maximal displacement from rat hepatocytes (p less than 0.025). However, sulphated insulin bound to liver membranes with an affinity more closely resembling that for adipocytes rather than hepatocytes. Differences in the intracellular processing of the negatively charged insulin could account for the observed lower affinity of binding to hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386580     DOI: 10.1007/bf00273803

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  SULFATED INSULIN FOR TREATMENT OF INSULIN-RESISTANT DIABETICS.

Authors:  P J MOLONEY; M A APRILE; S WILSON
Journal:  J New Drugs       Date:  1964 Sep-Oct

2.  A rapid method for the isolation of rat liver plasma membranes using an aqueous two-phase polymer system.

Authors:  L Lesko; M Donlon; G V Marinetti; J D Hare
Journal:  Biochim Biophys Acta       Date:  1973-06-22

3.  Insulin interactions with liver plasma membranes. Independence of binding of the hormone and its degradation.

Authors:  P Freychet; R Kahn; J Roth; D M Neville
Journal:  J Biol Chem       Date:  1972-06-25       Impact factor: 5.157

Review 4.  Insulin aggregation in artificial delivery systems.

Authors:  W D Lougheed; H Woulfe-Flanagan; J R Clement; A M Albisser
Journal:  Diabetologia       Date:  1980-07       Impact factor: 10.122

5.  The interaction of insulin with its receptor: cross-linking via insulin association as the source of receptor clustering.

Authors:  P D Jeffrey
Journal:  Diabetologia       Date:  1982-11       Impact factor: 10.122

6.  A monomeric insulin from the porcupine (Hystrix cristata), an Old World hystricomorph.

Authors:  R Horuk; T L Blundell; N R Lazarus; R W Neville; D Stone; A Wollmer
Journal:  Nature       Date:  1980-08-21       Impact factor: 49.962

7.  Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.

Authors:  J M Olefsky
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

8.  Preparation and properties of covalently linked insulin dimers.

Authors:  A Schüttler; D Brandenburg
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1982-03

9.  Long-term continuous intravenous insulin therapy with a portable insulin dosage-regulating apparatus.

Authors:  K Irsigler; H Kritz
Journal:  Diabetes       Date:  1979-03       Impact factor: 9.461

10.  Insulin receptor binding and receptor-mediated insulin degradation in human adipocytes.

Authors:  O Pedersen; E Hjøllund; H Beck-Nielsen; H O Lindskov; O Sonne; J Gliemann
Journal:  Diabetologia       Date:  1981-06       Impact factor: 10.122

View more
  5 in total

1.  Epidermal growth factor counteracts the glycogenic effect of insulin in parenchymal hepatocyte cultures.

Authors:  M H Chowdhury; L Agius
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

2.  The role of cell swelling in the stimulation of glycogen synthesis by insulin.

Authors:  M al-Habori; M Peak; T H Thomas; L Agius
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

3.  Biological effects of sulphated insulin in adipocytes and hepatocytes.

Authors:  S Zeuzem; R Taylor; L Agius; K Schoeffling; A M Albisser; K G Alberti
Journal:  Mol Cell Biochem       Date:  1985-10       Impact factor: 3.396

4.  In vitro activity of biosynthetic human diarginylinsulin.

Authors:  S Zeuzem; E Stahl; E Jungmann; M Zoltobrocki; K Schöffling; W F Caspary
Journal:  Diabetologia       Date:  1990-02       Impact factor: 10.122

5.  Effect of metabolic clearance rate and hepatic extraction of insulin on hepatic and peripheral contributions to hypoglycemia.

Authors:  Z Chap; T Ishida; J Chou; C J Hartley; R M Lewis; M Entman; J B Field
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.